Your HCP journey map is a lie
Here's something we see repeatedly: HCP customer journey maps that look amazing in presentations but don't match reality. Whether we're fixing existing journey maps or building them from scratch, the challenge is always the same: assumptions versus actual HCP behavior.
There's something satisfying about mapping out Dr. Smith's path to prescribing as a clean flow. Email awareness, webinar engagement, clinical data review, prescription. It's logical and fits perfectly on a slide deck.
Except Dr. Smith didn't get the memo.
She heard about your product from a colleague at a congress, bookmarked a peer discussion during a late-night Google search, half-listened to a podcast during her commute, saw your rep briefly in the hallway, and then – three months later – finally circled back when a patient asked about it.
Why pharmaceutical omnichannel strategy matters
True omnichannel pharma marketing means each touchpoint doesn't exist in isolation. An HCP might start with your rep's presentation, download a clinical study from your email, check peer reviews, attend a virtual congress and complete their journey through your medical portal. Each channel reinforces the others.
But here's the trap: companies call it "omnichannel" when they're really doing "multichannel" with better coordination. Having a presence on eight platforms doesn't make you omnichannel. True omnichannel is about being in the right places at the right times, ensuring touchpoints connect to form a meaningful narrative.
Most pharma companies build these strategies on assumptions. Then the data tells a different story.
The Cost of Assumptions
We've worked with clients shocked to discover their HCPs barely opened emails but were highly active on LinkedIn. Others assumed live webinars were king, only to find on-demand podcasts drove more engagement.
The most common mistake? Treating omnichannel as "set it and forget it." Effective omnichannel marketing requires constant optimization based on how HCPs actually interact with your ecosystem.
An oncologist attends your symposium, downloads prescribing information, but doesn't engage further. Traditional multichannel stops there. Intelligent omnichannel adjusts – triggering a case study email or alerting your MSL that this physician is ready for a deeper conversation.
Why Getting It Wrong Is Expensive
Omnichannel execution isn't cheap. A robust pharmaceutical omnichannel strategy can run into six or seven figures annually.
Betting on the wrong channel mix means you're invisible to HCPs at the exact moments they're making prescribing decisions. Your competitors who got it right are building relationships while you're wondering why your content isn't working.
Poorly executed omnichannel damages your brand. A healthcare professional receives the same email three times while never getting the clinical data they requested. A MSL shows up unaware the physician already attended your webinar. A rep pitches benefits the HCP already knows.
That's not omnichannel. That's omnimess.
The solution is building your pharmaceutical marketing strategy on real behavioral data, not assumptions.
Track actual HCP engagement patterns. What works for cardiology might fall flat in psychiatry.
Test assumptions early and often. The channels that worked two years ago might be declining.
Look for unexpected paths. Sometimes a brief conversation at a booth turns out to be the critical moment.
Stay flexible when data contradicts your hypothesis. That flexibility separates good pharma marketing from great.
We help pharmaceutical clients move from "we think our HCPs do this" to "we know our HCPs do this."
The Only Map That Matters
The most elegant journey map is worthless if it doesn't reflect how HCPs actually move through their prescribing process. Your pharmaceutical omnichannel strategy needs to follow their reality, not force them into yours.
The HCP journey isn't linear. It's messy, multi-directional and different for every healthcare professional. The companies that win stop assuming and start measuring.
The healthcare professionals are already on their journey, making decisions right now. The question is whether you'll be there, in the right channel, when they need you.
By Ana Sara Ferreira, Omnichannel Lead at Float Health
Frequently Asked Questions (FAQs)
What is omnichannel pharma marketing?
Omnichannel pharma marketing creates seamless, connected experiences across multiple channels. Unlike multichannel where channels operate independently, omnichannel ensures each touchpoint connects and reinforces the others.
How is omnichannel different from multichannel?
Multichannel means presence on multiple platforms that operate in silos. Omnichannel integrates channels so they work together. If an HCP attends your webinar, that informs what email they receive next.
Why is the HCP journey non-linear?
HCPs don't follow predictable paths from awareness to prescription. Their decision-making is influenced by peer discussions, clinical evidence and patient needs across extended timeframes. This is why rigid, linear journey maps often fail.